CBS mentorship and Professional Development Program: Information Session
0 comments
by Neda Latifi
The Canadian Biomaterials Society is pleased to present The 2022-2023 CBS mentorship and Professional Development Program Join The 2nd Lab and the CBS-QC Student Chapter this Friday, October 7th, 2022 at 5 00 PM for a hybrid information session about this program...
BioInnovation Institute & Science Prize for Innovation
0 comments
by Amanda Clifford
Through the BioInnovation Institute Science Prize for Innovation, the editors of Science seek to recognize bold researchers who are asking fundamental questions at the intersection of the life sciences and entrepreneurship...
Call for Applications: CBS Mentorship And Professional Development Program
0 comments
by Amanda Clifford
We are pleased to open the call for applications for the CBS Mentorship and Professional Development, a program specifically designed to connect professionals outside of academia with graduate students and postdoctoral fellows coming from the Canadian biomaterial s community...
While injectable hydrogels have several advantages in the context of experimental medicine and tissue engineering, their relatively weak mechanical properties and isotropic network structure often limit their practical applications or translation to clinical use...
Developing biomimetic 3D constructs to study neuronal networks in vitro is critical to address the limitations of conventional 2D cultures used in pre-clinical studies...
Encapsulated, aligned nanofibers fabricated by solution electrospinning can serve as multifunctional biomaterial scaffolds, due to their desirable topographical and drug delivery properties 1 ...
Plasma Electrolytic Oxidation PEO is a simple and cost effective electrochemical technique for the surface modification of metals which recently gained great interest in the biomedical field for its ability to generate a bioactive porous oxide layer on widely used orthopedic metals, such as titanium and its alloys 1 ...
Allergic conjunctivitis affects nearly 40 of the North American population 1 . Topical eye drops are the most common treatment method, but it is generally accepted that less than 5 of an applied dose remains bioavailable, resulting in frequent reapplication 2 , 3 ...
